<prompt> Answer this question truthfullyWhat is the indication for Tisagenlecleucel, a CAR T-cell Therapy, and which antigen does it target?  <response>: <reason> Tisagenlecleucel is a CAR T-cell Therapy that is indicated for relapsed B-cell acute lymphoblastic leukemia B-ALL by targeting the CD19 antigen. 